Predicting immunotherapy outcomes in patients with MSI tumors using NLR and CT global tumor volume.
Belkouchi Y, Nebot-Bral L, Lawrance L, Kind M, David C, Ammari S, Cournède PH, Talbot H, Vuagnat P, Smolenschi C, Kannouche PL, Chaput N, Lassau N, Hollebecque A.
Belkouchi Y, et al. Among authors: kind m.
Front Oncol. 2022 Oct 25;12:982790. doi: 10.3389/fonc.2022.982790. eCollection 2022.
Front Oncol. 2022.
PMID: 36387101
Free PMC article.